scholarly journals Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits

2017 ◽  
pp. btw745 ◽  
Author(s):  
Hon-Cheong So ◽  
Pak C. Sham
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Declan Bennett ◽  
Donal O’Shea ◽  
John Ferguson ◽  
Derek Morris ◽  
Cathal Seoighe

AbstractOngoing increases in the size of human genotype and phenotype collections offer the promise of improved understanding of the genetics of complex diseases. In addition to the biological insights that can be gained from the nature of the variants that contribute to the genetic component of complex trait variability, these data bring forward the prospect of predicting complex traits and the risk of complex genetic diseases from genotype data. Here we show that advances in phenotype prediction can be applied to improve the power of genome-wide association studies. We demonstrate a simple and efficient method to model genetic background effects using polygenic scores derived from SNPs that are not on the same chromosome as the target SNP. Using simulated and real data we found that this can result in a substantial increase in the number of variants passing genome-wide significance thresholds. This increase in power to detect trait-associated variants also translates into an increase in the accuracy with which the resulting polygenic score predicts the phenotype from genotype data. Our results suggest that advances in methods for phenotype prediction can be exploited to improve the control of background genetic effects, leading to more accurate GWAS results and further improvements in phenotype prediction.


2018 ◽  
Author(s):  
Urmo Võsa ◽  
Annique Claringbould ◽  
Harm-Jan Westra ◽  
Marc Jan Bonder ◽  
Patrick Deelen ◽  
...  

SummaryWhile many disease-associated variants have been identified through genome-wide association studies, their downstream molecular consequences remain unclear.To identify these effects, we performedcis-andtrans-expressionquantitative trait locus (eQTL) analysis in blood from 31,684 individuals through the eQTLGen Consortium.We observed thatcis-eQTLs can be detected for 88% of the studied genes, but that they have a different genetic architecture compared to disease-associated variants, limiting our ability to usecis-eQTLs to pinpoint causal genes within susceptibility loci.In contrast, trans-eQTLs (detected for 37% of 10,317 studied trait-associated variants) were more informative. Multiple unlinked variants, associated to the same complex trait, often converged on trans-genes that are known to play central roles in disease etiology.We observed the same when ascertaining the effect of polygenic scores calculated for 1,263 genome-wide association study (GWAS) traits. Expression levels of 13% of the studied genes correlated with polygenic scores, and many resulting genes are known to drive these traits.


2021 ◽  
Author(s):  
Declan Bennett ◽  
Dónal O'Shea ◽  
John Ferguson ◽  
Derek Morris ◽  
Cathal Seoighe

Abstract Ongoing increases in the size of human genotype and phenotype collections offer the promise of improved understanding of the genetics of complex diseases. In addition to the biological insights that can be gained from the nature of the variants that contribute to the genetic component of complex trait variability, these data bring forward the prospect of predicting complex traits and the risk of complex genetic diseases from genotype data. Here we show that advances in phenotype prediction can be applied to improve the power of genome-wide association studies. We demonstrate a simple and efficient method to model genetic background effects using polygenic scores derived from SNPs that are not on the same chromosome as the target SNP. Using simulated and real data we found that this can result in a substantial increase in the number of variants passing genome-wide significance thresholds. This increase in power to detect trait-associated variants also translates into an increase in the accuracy with which the resulting polygenic score predicts the phenotype from genotype data. Our results suggest that advances in methods for phenotype prediction can be exploited to improve the control of background genetic effects, leading to more accurate GWAS results and further improvements in phenotype prediction.


2021 ◽  
Vol 42 (1) ◽  
Author(s):  
Dinesh K. Saini ◽  
Yuvraj Chopra ◽  
Jagmohan Singh ◽  
Karansher S. Sandhu ◽  
Anand Kumar ◽  
...  

Author(s):  
Nasa Sinnott-Armstrong ◽  
Sahin Naqvi ◽  
Manuel Rivas ◽  
Jonathan K Pritchard

SummaryGenome-wide association studies (GWAS) have been used to study the genetic basis of a wide variety of complex diseases and other traits. However, for most traits it remains difficult to interpret what genes and biological processes are impacted by the top hits. Here, as a contrast, we describe UK Biobank GWAS results for three molecular traits—urate, IGF-1, and testosterone—that are biologically simpler than most diseases, and for which we know a great deal in advance about the core genes and pathways. Unlike most GWAS of complex traits, for all three traits we find that most top hits are readily interpretable. We observe huge enrichment of significant signals near genes involved in the relevant biosynthesis, transport, or signaling pathways. We show how GWAS data illuminate the biology of variation in each trait, including insights into differences in testosterone regulation between females and males. Meanwhile, in other respects the results are reminiscent of GWAS for more-complex traits. In particular, even these molecular traits are highly polygenic, with most of the variance coming not from core genes, but from thousands to tens of thousands of variants spread across most of the genome. Given that diseases are often impacted by many distinct biological processes, including these three, our results help to illustrate why so many variants can affect risk for any given disease.


2019 ◽  
Author(s):  
Jan A. Freudenthal ◽  
Markus J. Ankenbrand ◽  
Dominik G. Grimm ◽  
Arthur Korte

AbstractMotivationGenome-wide association studies (GWAS) are one of the most commonly used methods to detect associations between complex traits and genomic polymorphisms. As both genotyping and phenotyping of large populations has become easier, typical modern GWAS have to cope with massive amounts of data. Thus, the computational demand for these analyses grew remarkably during the last decades. This is especially true, if one wants to implement permutation-based significance thresholds, instead of using the naïve Bonferroni threshold. Permutation-based methods have the advantage to provide an adjusted multiple hypothesis correction threshold that takes the underlying phenotypic distribution into account and will thus remove the need to find the correct transformation for non Gaussian phenotypes. To enable efficient analyses of large datasets and the possibility to compute permutation-based significance thresholds, we used the machine learning framework TensorFlow to develop a linear mixed model (GWAS-Flow) that can make use of the available CPU or GPU infrastructure to decrease the time of the analyses especially for large datasets.ResultsWe were able to show that our application GWAS-Flow outperforms custom GWAS scripts in terms of speed without loosing accuracy. Apart from p-values, GWAS-Flow also computes summary statistics, such as the effect size and its standard error for each individual marker. The CPU-based version is the default choice for small data, while the GPU-based version of GWAS-Flow is especially suited for the analyses of big data.AvailabilityGWAS-Flow is freely available on GitHub (https://github.com/Joyvalley/GWAS_Flow) and is released under the terms of the MIT-License.


2019 ◽  
Vol 28 (1) ◽  
pp. 82-90 ◽  
Author(s):  
Daniel W. Belsky ◽  
K. Paige Harden

Genome-wide association studies (GWASs) have identified specific genetic variants associated with complex human traits and behaviors, such as educational attainment, mental disorders, and personality. However, small effect sizes for individual variants, uncertainty regarding the biological function of discovered genotypes, and potential “outside-the-skin” environmental mechanisms leave a translational gulf between GWAS results and scientific understanding that will improve human health and well-being. We propose a set of social, behavioral, and brain-science research activities that map discovered genotypes to neural, developmental, and social mechanisms and call this research program phenotypic annotation. Phenotypic annotation involves (a) elaborating the nomological network surrounding discovered genotypes, (b) shifting focus from individual genes to whole genomes, and (c) testing how discovered genotypes affect life-span development. Phenotypic-annotation research is already advancing the understanding of GWAS discoveries for educational attainment and schizophrenia. We review examples and discuss methodological considerations for psychologists taking up the phenotypic-annotation approach.


Sign in / Sign up

Export Citation Format

Share Document